FR2799461B1 - Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments - Google Patents

Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments

Info

Publication number
FR2799461B1
FR2799461B1 FR9912643A FR9912643A FR2799461B1 FR 2799461 B1 FR2799461 B1 FR 2799461B1 FR 9912643 A FR9912643 A FR 9912643A FR 9912643 A FR9912643 A FR 9912643A FR 2799461 B1 FR2799461 B1 FR 2799461B1
Authority
FR
France
Prior art keywords
chain
medicaments
preparation
application
heterocycle derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9912643A
Other languages
English (en)
Other versions
FR2799461A1 (fr
Inventor
De Lassauniere Pierre Chabrier
Jeremiah Harnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to FR9912643A priority Critical patent/FR2799461B1/fr
Priority to TW089121109A priority patent/TWI283577B/zh
Priority to TW093132951A priority patent/TWI292316B/zh
Priority to NZ518304A priority patent/NZ518304A/en
Priority to AT00967988T priority patent/ATE338547T1/de
Priority to RU2005112774/04A priority patent/RU2380362C2/ru
Priority to HU0203841A priority patent/HU228254B1/hu
Priority to AT02076763T priority patent/ATE522213T1/de
Priority to KR1020077013941A priority patent/KR20070068491A/ko
Priority to IL14889600A priority patent/IL148896A0/xx
Priority to ES00967988T priority patent/ES2270873T3/es
Priority to MYPI20004725A priority patent/MY145388A/en
Priority to CNA2009101297620A priority patent/CN101559053A/zh
Priority to EP02076763A priority patent/EP1228760B1/fr
Priority to EP05076749.0A priority patent/EP1589007B1/fr
Priority to NZ533429A priority patent/NZ533429A/en
Priority to MXPA02003665A priority patent/MXPA02003665A/es
Priority to AU77965/00A priority patent/AU783129B2/en
Priority to PL355147A priority patent/PL215580B1/pl
Priority to PT50767490T priority patent/PT1589007E/pt
Priority to CA2388505A priority patent/CA2388505C/fr
Priority to DK00967988T priority patent/DK1223933T3/da
Priority to DK05076749.0T priority patent/DK1589007T3/en
Priority to EP00967988A priority patent/EP1223933B1/fr
Priority to PCT/FR2000/002805 priority patent/WO2001026656A2/fr
Priority to ES02076763T priority patent/ES2370274T3/es
Priority to CNB008158479A priority patent/CN100488506C/zh
Priority to PT00967988T priority patent/PT1223933E/pt
Priority to JP2001529718A priority patent/JP4972263B2/ja
Priority to DE60030574T priority patent/DE60030574T2/de
Priority to KR1020027004578A priority patent/KR100731698B1/ko
Priority to ES05076749.0T priority patent/ES2544856T3/es
Priority to RU2002112227/15A priority patent/RU2271355C2/ru
Priority to BR0014649-8A priority patent/BR0014649A/pt
Priority to CZ2002-1292A priority patent/CZ304331B6/cs
Priority to ARP000105353A priority patent/AR029006A1/es
Publication of FR2799461A1 publication Critical patent/FR2799461A1/fr
Application granted granted Critical
Publication of FR2799461B1 publication Critical patent/FR2799461B1/fr
Priority to IL148896A priority patent/IL148896A/en
Priority to NO20021689A priority patent/NO331874B1/no
Priority to HK03101645.4A priority patent/HK1049957B/zh
Priority to US10/681,002 priority patent/US20040132788A1/en
Priority to US10/915,001 priority patent/US7291641B2/en
Priority to US10/575,249 priority patent/US20070054900A1/en
Priority to US11/256,901 priority patent/US20070021390A1/en
Priority to CY20061101600T priority patent/CY1106237T1/el
Priority to US11/708,531 priority patent/US20070179153A1/en
Priority to IL185118A priority patent/IL185118A0/en
Priority to US12/001,439 priority patent/US7956075B2/en
Priority to RU2009136591/04A priority patent/RU2530882C2/ru
Priority to US13/053,092 priority patent/US8288560B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9912643A 1999-10-11 1999-10-11 Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments Expired - Lifetime FR2799461B1 (fr)

Priority Applications (49)

Application Number Priority Date Filing Date Title
FR9912643A FR2799461B1 (fr) 1999-10-11 1999-10-11 Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
TW089121109A TWI283577B (en) 1999-10-11 2000-10-09 Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
TW093132951A TWI292316B (en) 1999-10-11 2000-10-09 Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof
NZ518304A NZ518304A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, their production and use to inhibit monoamine oxydases (MAO) and/or lipidic peroxidation and/or to act as modulators of the sodium channels
AT00967988T ATE338547T1 (de) 1999-10-11 2000-10-10 Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
RU2005112774/04A RU2380362C2 (ru) 1999-10-11 2000-10-10 Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
HU0203841A HU228254B1 (en) 1999-10-11 2000-10-10 5-membered heteroaromatic compound and pharmaceutical compositions containing it
AT02076763T ATE522213T1 (de) 1999-10-11 2000-10-10 Fünfgliedrige-heteroringderivate , ihre herstellung und ihre verwendung als arzneimittel
KR1020077013941A KR20070068491A (ko) 1999-10-11 2000-10-10 5-원 헤테로사이클 유도체, 이의 제조 방법 및의약으로서의 이의 용도
IL14889600A IL148896A0 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
ES00967988T ES2270873T3 (es) 1999-10-11 2000-10-10 Derivados de heterociclos de 5 miembros y su aplicacion como inhibidores de monoamina oxidasa.
MYPI20004725A MY145388A (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and sue thereof as medicaments
CNA2009101297620A CN101559053A (zh) 1999-10-11 2000-10-10 5-元杂环衍生物、其制备及其作为药物的用途
EP02076763A EP1228760B1 (fr) 1999-10-11 2000-10-10 Dérivés d'hétérocycles à 5 chaînons, leur préparation et leur application à titre de médicaments
EP05076749.0A EP1589007B1 (fr) 1999-10-11 2000-10-10 Dérivés d'hétérocycles à 5 chainons, leur préparation et leur application comme médicaments
NZ533429A NZ533429A (en) 1999-10-11 2000-10-10 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
MXPA02003665A MXPA02003665A (es) 1999-10-11 2000-10-10 Derivados de heterociclos de 5 miembros, su preparacion y su uso como medicamentos.
AU77965/00A AU783129B2 (en) 1999-10-11 2000-10-10 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
PL355147A PL215580B1 (pl) 1999-10-11 2000-10-10 4-[2-(aminometylo)-1,3-tiazol-4-ilo]-2,6-di(tert-butylo) fenol i jego zastosowanie jako leku
PT50767490T PT1589007E (pt) 1999-10-11 2000-10-10 Derivados de heterociclos de cinco membros, sua preparação e sua aplicação como medicamentos
CA2388505A CA2388505C (fr) 1999-10-11 2000-10-10 Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
DK00967988T DK1223933T3 (da) 1999-10-11 2000-10-10 5-leddet derivater af heterocyklusser og deres anvendelse som monoaminoxidaseinhibitorer
DK05076749.0T DK1589007T3 (en) 1999-10-11 2000-10-10 5-link heterocycle derivatives, their preparation and use as pharmaceuticals
EP00967988A EP1223933B1 (fr) 1999-10-11 2000-10-10 Dérivés d'hétérocycles à 5 chainons et leur application comme inhibiteurs de monoamine oxydase
PCT/FR2000/002805 WO2001026656A2 (fr) 1999-10-11 2000-10-10 Derives d'heterocycles a 5 chainons et leur application comme inhibiteurs de monoamine oxydase
ES02076763T ES2370274T3 (es) 1999-10-11 2000-10-10 Derivados de heterociclos de 5 miembros, su preparación y su aplicación como medicamentos.
CNB008158479A CN100488506C (zh) 1999-10-11 2000-10-10 5-元杂环衍生物、其制备及其作为药物的用途
PT00967988T PT1223933E (pt) 1999-10-11 2000-10-10 Derivados de heterociclos com 5 membros e sua utilização como inibidores de monoamina oxidase
JP2001529718A JP4972263B2 (ja) 1999-10-11 2000-10-10 ５員複素環誘導体、その製造方法及びその医薬としての使用
DE60030574T DE60030574T2 (de) 1999-10-11 2000-10-10 Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
KR1020027004578A KR100731698B1 (ko) 1999-10-11 2000-10-10 5-원 헤테로사이클 유도체, 이의 제조 방법 및의약으로서의 이의 용도
ES05076749.0T ES2544856T3 (es) 1999-10-11 2000-10-10 Derivados de heterociclos de 5 miembros, su preparación y su aplicación como medicamentos
RU2002112227/15A RU2271355C2 (ru) 1999-10-11 2000-10-10 Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
BR0014649-8A BR0014649A (pt) 1999-10-11 2000-10-10 Utilização de um produto, medicamento, composto e composição farmacêutica
CZ2002-1292A CZ304331B6 (cs) 1999-10-11 2000-10-10 Použití thiazolových derivátů pro přípravu léčiva
ARP000105353A AR029006A1 (es) 1999-10-11 2000-10-11 Derivados de heterociclos con 5 miembros, su preparacion y su uso como medicamentos
IL148896A IL148896A (en) 1999-10-11 2002-03-26 Use of thiazole derivatives for drug preparation, pharmaceutical preparations containing them and one such compound
NO20021689A NO331874B1 (no) 1999-10-11 2002-04-10 4-[2(aminometyl)-1,3-tiazol-4-yl]-2,6-di(tert-butyl)fenol, anvendelse som medikamenter samt anvendelse for behandling av sykdom.
HK03101645.4A HK1049957B (zh) 1999-10-11 2003-03-06 5-元雜環衍生物、其製備及其作為藥物的用途
US10/681,002 US20040132788A1 (en) 1999-10-11 2003-10-08 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US10/915,001 US7291641B2 (en) 1999-10-11 2004-08-10 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
US10/575,249 US20070054900A1 (en) 1999-10-11 2004-10-08 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
US11/256,901 US20070021390A1 (en) 1999-10-11 2005-10-24 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
CY20061101600T CY1106237T1 (el) 1999-10-11 2006-11-08 Ετepοκυκλικα παραγωγα με 5 μελη στο δακτυλιο και εφαρμογη αυτων ως παρεμποδιστων της μονοαμινο οξυδασης
US11/708,531 US20070179153A1 (en) 1999-10-11 2007-02-20 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
IL185118A IL185118A0 (en) 1999-10-11 2007-08-08 5-membered heterocycle derivatives,production thereof and use thereof as medicaments
US12/001,439 US7956075B2 (en) 1999-10-11 2007-12-11 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
RU2009136591/04A RU2530882C2 (ru) 1999-10-11 2009-10-02 Производные пятичленных гетероциклов, способ их получения и их применение в качестве лекарственных средств
US13/053,092 US8288560B2 (en) 1999-10-11 2011-03-21 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912643A FR2799461B1 (fr) 1999-10-11 1999-10-11 Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments

Publications (2)

Publication Number Publication Date
FR2799461A1 FR2799461A1 (fr) 2001-04-13
FR2799461B1 true FR2799461B1 (fr) 2002-01-04

Family

ID=9550778

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9912643A Expired - Lifetime FR2799461B1 (fr) 1999-10-11 1999-10-11 Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments

Country Status (3)

Country Link
CN (1) CN101559053A (fr)
ES (1) ES2370274T3 (fr)
FR (1) FR2799461B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110240557B (zh) * 2018-03-08 2023-05-09 广东东阳光药业有限公司 吡咯烷酰胺衍生物及其用途
CN111018802B (zh) * 2019-12-03 2021-07-06 湖北大学 具有抗帕金森氏症的化合物、制备方法及其应用
CN113912528B (zh) * 2020-07-07 2023-06-09 广东东阳光药业有限公司 吡咯烷酰胺衍生物的盐及其用途
CN115959977B (zh) * 2022-12-28 2024-06-11 陕西泰合利华工业有限公司 一种1,1,1-三(3,5-二甲氧基甲基-4-羟基苯基)乙烷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
CA2302294A1 (fr) * 1997-08-28 1999-03-04 Harlan Edgar Shannon Procede de traitement d'une douleur

Also Published As

Publication number Publication date
CN101559053A (zh) 2009-10-21
FR2799461A1 (fr) 2001-04-13
ES2370274T3 (es) 2011-12-14

Similar Documents

Publication Publication Date Title
PT1589007E (pt) Derivados de heterociclos de cinco membros, sua preparação e sua aplicação como medicamentos
EE04964B1 (et) Imidaso[1,2a]pridiini ja prasolo[2,3a]pridiiniderivaadid
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
MA26816A1 (fr) Derives d'amino-triazolopyridine
PT1218378E (pt) Derivados de terc-butil-(7-metil-imidazo-¬1,2-a|-piridin-3-il)-amina
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
IL144501A0 (en) Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
CZ20004592A3 (cs) Benzo(b)thiepin-1,1-dioxidové deriváty, způsob jejich přípravy, léčiva obsahující tyto sloučeniny a jejich použití
IL150346A (en) Benzazole derivatives, their preparation and pharmaceutical compositions containing them
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR14C0044I2 (fr) Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
HUP0204154A3 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
FR2799461B1 (fr) Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
HUP0201810A2 (en) Sootepenseone and its derivatives, their preparation and use as medicament
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
FR2823208B1 (fr) Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2812546B1 (fr) Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19